An official website of the United States government
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Trial Status: active
The study is an observational multicenter evaluation of participants with colorectal
cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition
to their standard-of-care therapy and disease surveillance.
Inclusion Criteria
Known or suspected colorectal adenocarcinoma (Stage I to IVA disease)
Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent.
18 years old or older
Willing and able to provide informed consent
Willing to have additional blood samples collected during routine surveillance visits
Exclusion Criteria
Not willing to have additional blood samples collected
Pathology that is not consistent with colorectal adenocarcinoma
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05234177.
Locations matching your search criteria
United States
Ohio
Columbus
Ohio State University Comprehensive Cancer Center
Status: Temporarily closed to accrual
Name Not Available
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
